Clinical Trial Update: A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or Metformin [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of Topiramate OROS Controlled-Release in obese adults with Type 2 diabetes mellitus managed with diet or metfor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Topiramate OROS Controlled-Release (topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Obesity, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED